TGFBR2 and intestinal neoplasm: We previously constructed compound mutant mice that carried ApcΔ716 (A), KrasG12D (K), Tgfbr2-/-(T), and Trp53R270H (P) mutations in various combinations and established intestinal tumor-derived organoids with different genotypes8–10.